Vascular Solutions takes thrombus tech to Japan
This article was originally published in Clinica
Vascular Solutions is to start selling in Japan its Pronto catheter, a device that uses mechanical aspiration to remove acute thrombus from the arterial system. The Minneapolis, Minnesota firm said it had received notification from its Japanese distributor Nihon Kohden that the import licence and reimbursement notification for the product's sale in Japan had been completed. "After the US...Japan is the second largest market for thrombus aspiration catheters," said Howard Root, Vascular Solutions' CEO. "Removal of acute thrombus is a potential $100m annual worldwide market opportunity that we are only beginning to realise with the Pronto as it enters its second year of commercial launch and expanding worldwide markets." Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.